Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Multidisciplinary Approaches to Paraneoplastic LEMS: Insights for Healthcare Decision-Makers : Episode 4
Using Technology for Early Detection of LEMS
A panelist discusses how enhanced screening protocols combined with predictive analytics can accelerate Lambert-Eaton myasthenic syndrome (LEMS) detection in high-risk populations like patients with small cell lung cancer (SCLC) while also exploring the potential of telemedicine to improve early diagnosis in underserved communities.
EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection
EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS
EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care
Now Viewing
EP: 4.Using Technology for Early Detection of LEMS
EP: 5.Team- and System-Based Approaches to Managing LEMS and Ensuring Access
EP: 6.The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care
EP: 7.Managed Care Partnerships and Continuity of Care
Video content above is prompted by the following:
- How can improved screening protocols and the integration of predictive analytics in clinical practice enhance early detection of LEMS in high-risk patients, such as those with SCLC, and which patient populations should be prioritized?
- In what ways can telemedicine and digital health tools support earlier detection of LEMS, especially in underserved areas?
Related Videos
Related Content
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025Article
The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More
